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ABSTRACT
Multiple sclerosis (MS) is an immune-mediated disease that affects the central nervous 
system. Clinical presentation and prevalence vary widely around the world. Objective: 
To describe the clinical and epidemiological aspects of patients with MS in Uberaba 
(MG). Method: We conducted a transversal descriptive study, with data analysis of 35 
patients with MS. Results: Prevalence of MS was 12.5 cases/100,000 inhabitants, with a 
predominance in females (71.4%) and Caucasoid (85.7%). The current average age was 
(43.8 ys). The most common initial symptom was sensory (40%), followed by optical neuritis 
(25.7%). Expanded Disability Status Scale average score was 2.4. The relapsing-remitting 
form was predominant (88.6%), most (74.3%) were on immunomodulatory treatment and 
(40%) had college education. Conclusion: Prevalence of MS in Uberaba (MG) is considered 
average in accordance to Kurtzke and Page and clinical features are consistent with most 
Brazilian studies.
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RESUMO
A esclerose múltipla (EM) é uma doença imunomediada que acomete o sistema nervoso 
central. Seus aspectos clínicos e prevalência variam consideravelmente em todo o 
mundo. Objetivo: Descrever a prevalência, os aspectos clínicos e epidemiológicos dos 
pacientes com EM na cidade de Uberaba (MG). Método: Realizado estudo descritivo 
transversal, com análise dos dados de 35 pacientes com EM. Resultados: A prevalência 
de EM foi de 12,5 casos/100.000 habitantes, com predomínio no sexo feminino (71,4%) 
e etnia caucasóide (85,7%), idade média atual de 43,8 anos. Do total, 40 possuem curso 
superior. O sintoma inicial mais frequente foi o sensitivo (40%), seguido de neurite óptica 
(25,7%). A média dos escores da Escala de Status de Incapacidade Expandida foi de 
2,4. A forma evolutiva recorrente-remitente foi predominante (88,6%), com (74,3%) dos 
pacientes em uso de imunomodulador. Conclusão: A prevalência de EM no município de 
Uberaba (MG) é considerada média, de acordo com Kurtzke e Page. Os aspectos clínico-
epidemiológicos estão em consonância com a maioria dos estudos brasileiros.
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Multiple sclerosis (MS) is an inflam-
atory demyelinating disease affecting the 
central nervous system (CNS), with pre-
sumed autoimmune etiology1,2. It affects 
mostly young adults, leading to the emer-
gence of various signs and symptoms, 
often disabling, with no estimated dura-
tion and possible remission². The neuro-
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logical symptoms of this disease are manifestations of 
inflammatory reaction of the central nervous system 
(CNS) and, over the long term they reflect the degen-
erative aggression against a variety of functional neuro-
logical systems3. Genetic and environmental factors are 
unequivocally related to susceptibility and expression of 
the disease4. MS displays an unimodal distribution be-
tween 20-40 years of age, with a higher incidence in fe-
males and Caucasians2,5.
The prevalence of MS varies considerably around the 
world, being higher in regions located between the paral-
lels 44 and 64N. Areas considered as of high prevalence 
are those with more than 30 cases per 100,000, average 
prevalence areas with 5 to 30/100,000, and low preva-
lence areas less than 5/100,0002,3,5-7. MS seems to be a 
relatively rare disease in South American in comparison 
with Northern hemisphere Countries2,6. Brazil is con-
sidered a low prevalence area, however, there are me-
dium-prevalence areas, as shown in studies from cities 
such as São Paulo8, Belo Horizonte9, Santos10, Botucatu11 
and Sorocaba12. 
Uberaba is located in the state of Minas Gerais, with 
a latitude of 19°45’27 West and longitude of 47°55’36. 
The climate in this region according to Köppen’s raking is 
AW, that is characterized by two seasons: a cold and dry 
winter and a hot and wet summer, with an average an-
nual temperature of 23.2°C, an annual average humidity 
of 64% and an altitude of 764 meters13. According to the 
Brazilian Institute of Geography and Statistics (IBGE)13, 
the city occupies 256 Km2 of urban area, with a total area 
of 4,512.14 Km2. Its population is of 287,760 inhabitants, 
with an annual growth rate of 1.96%, urbanization rate 
of 96.9%, a population density of 55.4 inhabitants/Km2, 
a HDI (Human Development Index) of 0.834, and a life 
expectancy of 73 years13. The main economic activities 
are industry, commerce, agriculture and cattle breeding 
(IBGE)14. The city has 2 teaching hospitals, 6 private hos-
pitals, 2 radiological clinics with MRI, 2 CSF laborato-
ries, 1004 physicians, of which 16 are neurologists and 
6 neurosurgeons.
METHOD
This is a transversal descriptive study, with patients 
from the Grupo de Estudo e Pesquisa em Esclerose 
Múltipla (GEPEM), outpatients from the Universidade 
Federal do Triângulo Mineiro (UFTM) and from the As-
sociação Uberabense de Amigos e Portadores de Escle-
rose Múltipla (AUAPEM), private clinics, radiological 
clinics, and data from Uberaba’s Heath Department13. 
A cross-sectional study was held from August to 
December 2008. The patients were classified in accor-
dance with the criteria of Poser3 and McDonald15 and 
only those with defined multiple sclerosis were registred.
Data was collected according to the method pro-
posed by LACTRIMS (Latin American Committee for 
Treatment and Research in Multiple Sclerosis)16 from pa-
tients’ medical files, with prior knowledge and signature 
of a term of clarification and free consent. This study was 
Table 1. Distribution of epidemiological data from patients with multiple sclerosis in Uberaba (MG).
Epidemiological data
Gender 
Total
Male Female
N % N % 
Current age
   >20 years 1 10 – – 1
   20-30 years 1 10 6 24 7
   31-40 years 3 33.3 4 16 7
   41-50 years 1 10 9 36 10
   51-60 years 2 20 3 12 5
   >60 years 2 20 3 12 5
Ethnic group
   White 7 70 23 92 30
   Black – – – – –
   Pheodermic 3 30 2 8 5
Level of education
   Elementary school 4 40 3 12 7
   High school 3 33.3 11 44 14
   University studies 3 33.3 11 44 14
Source: patients with MS-GEPEM-UFTM, AUAPEM, private clinics.
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approved by the Research Ethics Committee of UFTM, 
under protocol number 884/2007. The epidemiological 
variables were: gender, age, ethnicity, initial symptom, 
clinical forms, use of immunomodulators, elapsed time 
of disease, EDSS (expanded disability status scale)17, and 
level of education.
RESULTS
A total of 35 patients with MS were identified in 
Uberaba, resulting in a prevalence of 12.5 cases/100,000 
inhabitants. Among these 35 patients, 25 (71.4%) were 
female, ratio 2.5:1; 30 (85.7%) White; an mean age at 
onset was 43.8 years for females and 44 for males. Re-
garding level of education, 7 patients (20%) completed 
elementary school, 14 (40%) high school and 14 (40%) 
concluded university studies. The epidemiologic data are 
described on Table 1. At the time of diagnosis, the av-
erage age was 37.3 years for males and 37.4 for females. 
Mean disease duration was of 6.7 years, ranging from 3 
months to 35 years. The average current EDSS was 2.4, 
with values between 1 and 7.5. Details about data related 
to the disease are found in Table 2.
DISCUSSION
In Uberaba the prevalence of MS is of 12.5 cases/ 
100,000 inhabitants, configurating an average prevalence 
in accordance to findings by Kurtzke7, and in agreement 
with studies conducted in São Paulo8, Belo Horizonte9, 
Santos10. Botucatu11 and Sorocaba12. However, this prev-
alence is above other estimates18. The reasons for this 
discrepancy between Brazilian regions may be linked to 
genetic, environmental, ethnic, and socio-economical 
factors and differences in access to health services. Be-
sides, MS is a disease whose diagnosis requires an ex-
tensive list of complementary tests, neurological exper-
tise, in addition to a vast list of differential diagnosis. All 
these features underscore the importance of epidemio-
logical studies and the necessity for reference centers, 
in order to implement more reliable diagnoses and to 
demonstrate as closely as possible the real prevalence of 
MS. The medium age at the time of diagnosis for both 
genders is above averages obtained in similar studies19,20.
The White ethnic group was predominant, in agree-
ment with most Brazilian statistics21,22, except in a survey 
conducted in Recife, Brazil, in which the African Bra-
zilian ethnic group was responsible for (93.3%) of cases18. 
In this aspect, classifying patients according ethnic fac-
tors is a difficult task because of extensive racial miscege-
nation in Brazilian communities as well as the existence 
of many classifications.
The most common initial symptom was sensory 
(40%), followed by optical neuritis (25.7%) and brain-
stem/cerebellum symptoms (14.3%), in accordance to 
other studies23. As to educational status, 40% concluded 
university studies, an intriguing fact in a country where 
the vast majority does not even finish high school. The 
evolution form relapsing remitting occurred in most 
(88.6%) patients, in accordance to Brazilian and inter-
Table 2. Distribution of epidemiological data from patients with multiple sclerosis in Uberaba (MG).
Epimiological data
Gender
Total
Male Female
N % N %
Disease duration
   <1 year 2 20 – – 2
   1 a 5 years 5 50 13 52 18
   6 a 10 years 1 10 9 36 10
>10 years 2 20 3 12 5
Clinical forms
   Relapsing remitting 9 90 22 88 31
Secondary progressive – – 2 8 2
Primary progressive 1 10 1 4 2
Initial symptom
   Optical neuritis 1 10 8 32 9
   Brainstem/cerebellum 2 20 3 12 5
   Sensory 4 40 10 40 14
   Motor 1 10 2 8 3
   Others 2 20 2 8 4
Source: patients with MS-GEPEM-UFTM, AUAPEM, private clinics.
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national literature24. Out of all patients with MS in this 
study, 25.7% were not receiving immunomodulatory 
treatment. There are some possible reasons for this ap-
parent delay in the implementation of treatment, consid-
ering that the ultimate decision on beginning medication 
is also made by the patient, after presentation of current 
medical knowledge. This study aimed to demonstrate the 
epidemiological profile of patients with MS in Uberaba, 
where there is a reference center in MS (GEPEM) and 
good quality public and private health system when com-
pared to other less developed regions in Brazil, facili-
tating diagnoses of diseases that require expensive com-
plementary tests and medical specialists.
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